% This is the RIPE Database query service.
% The objects are in RPSL format.
%
% The RIPE Database is subject to Terms and Conditions.
% See https://docs.db.ripe.net/terms-conditions.html

% Information related to 'AS213307'

% Abuse contact for 'AS213307' is '[email protected]'

aut-num: AS213307
as-name: Idorsia-Pharmaceuticals-LTD
org: ORG-IPL22-RIPE
import: from AS8220 accept ANY
export: to AS8220 announce AS213307
import: from AS15404 accept ANY
export: to AS15404 announce AS213307
admin-c: NI1018-RIPE
tech-c: NI1018-RIPE
status: ASSIGNED
mnt-by: RIPE-NCC-END-MNT
mnt-by: mnt-ch-idorsia-1
created: 2020-04-29T08:28:27Z
last-modified: 2020-08-20T07:59:08Z
source: RIPE

organisation: ORG-IPL22-RIPE
org-name: Idorsia Pharmaceuticals Ltd
country: CH
org-type: LIR
address: Hegenheimermattweg 91
address: 4123
address: Allschwil
address: SWITZERLAND
phone: +41 58 844 00 00
e-mail: [email protected]
admin-c: NI1018-RIPE
tech-c: NI1018-RIPE
abuse-c: AR57204-RIPE
mnt-ref: mnt-ch-idorsia-1
mnt-by: RIPE-NCC-HM-MNT
mnt-by: mnt-ch-idorsia-1
created: 2019-12-16T13:10:15Z
last-modified: 2020-12-16T13:08:17Z
source: RIPE

role: NOC Idorsia
address: Hegenheimermattweg 91
address: 4123
address: Allschwil
address: SWITZERLAND
phone: +41 58 844 00 00
e-mail: [email protected]
nic-hdl: NI1018-RIPE
mnt-by: mnt-ch-idorsia-1
created: 2019-12-16T13:10:14Z
last-modified: 2019-12-16T13:10:15Z
source: RIPE

% This query was served by the RIPE Database Query Service version 1.114 (BUSA)